Capricor Therapeutics
CAPR
#7556
Rank
โ‚น47.25 B
Marketcap
โ‚น812.87
Share price
4.25%
Change (1 day)
50.94%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -โ‚น11.94 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น9.95 Billion a decrease over its 2024 earnings that were of -โ‚น3.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น11.94 Billion20.02%
2025 -โ‚น9.95 Billion159.57%
2024 -โ‚น3.83 Billion81.57%
2023 -โ‚น2.11 Billion-23.2%
2022 -โ‚น2.75 Billion44.93%
2021 -โ‚น1.9 Billion46.61%
2020 -โ‚น1.3 Billion78.71%
2019 -โ‚น0.73 Billion-49.7%
2018 -โ‚น1.44 Billion-724.78%
2017 โ‚น0.23 B-112.93%
2016 -โ‚น1.78 Billion46.27%
2015 -โ‚น1.22 Billion106.82%
2014 -โ‚น0.59 Billion-48.41%
2013 -โ‚น1.15 Billion977.23%
2012 -โ‚น0.11 Billion-77.11%
2011 -โ‚น0.47 Billion-22.35%
2010 -โ‚น0.6 Billion-20.17%
2009 -โ‚น0.75 Billion-41.17%
2008 -โ‚น1.27 Billion41.05%
2007 -โ‚น0.9 Billion1098.87%
2006 -โ‚น74.99 Million4101.55%
2005 -โ‚น1.79 Million-0.97%
2004 -โ‚น1.81 Million17.87%
2003 -โ‚น1.53 Million3.66%
2002 -โ‚น1.48 Million-30.11%
2001 -โ‚น2.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.480 T-20,351.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น77.43 B-732.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น84.6 Billion 590.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น30.84 Billion 151.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.6 Billion-95.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1.57 Billion-87.23%๐Ÿ‡บ๐Ÿ‡ธ USA